These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 30332462)

  • 1. Functional abnormalities in induced Pluripotent Stem Cell-derived cardiomyocytes generated from titin-mutated patients with dilated cardiomyopathy.
    Schick R; Mekies LN; Shemer Y; Eisen B; Hallas T; Ben Jehuda R; Ben-Ari M; Szantai A; Willi L; Shulman R; Gramlich M; Pane LS; My I; Freimark D; Murgia M; Santamaria G; Gherghiceanu M; Arad M; Moretti A; Binah O
    PLoS One; 2018; 13(10):e0205719. PubMed ID: 30332462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Regulation of Phosphodiesterases 2A and 3A Underlies Compromised β-Adrenergic Signaling in an iPSC Model of Dilated Cardiomyopathy.
    Wu H; Lee J; Vincent LG; Wang Q; Gu M; Lan F; Churko JM; Sallam KI; Matsa E; Sharma A; Gold JD; Engler AJ; Xiang YK; Bers DM; Wu JC
    Cell Stem Cell; 2015 Jul; 17(1):89-100. PubMed ID: 26095046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.
    Streckfuss-Bömeke K; Tiburcy M; Fomin A; Luo X; Li W; Fischer C; Özcelik C; Perrot A; Sossalla S; Haas J; Vidal RO; Rebs S; Khadjeh S; Meder B; Bonn S; Linke WA; Zimmermann WH; Hasenfuss G; Guan K
    J Mol Cell Cardiol; 2017 Dec; 113():9-21. PubMed ID: 28941705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy.
    Hinson JT; Chopra A; Nafissi N; Polacheck WJ; Benson CC; Swist S; Gorham J; Yang L; Schafer S; Sheng CC; Haghighi A; Homsy J; Hubner N; Church G; Cook SA; Linke WA; Chen CS; Seidman JG; Seidman CE
    Science; 2015 Aug; 349(6251):982-6. PubMed ID: 26315439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the cardiac pathology of SCO2-mediated hypertrophic cardiomyopathy using patients induced pluripotent stem cell-derived cardiomyocytes.
    Hallas T; Eisen B; Shemer Y; Ben Jehuda R; Mekies LN; Naor S; Schick R; Eliyahu S; Reiter I; Vlodavsky E; Katz YS; Õunap K; Lorber A; Rodenburg R; Mandel H; Gherghiceanu M; Binah O
    J Cell Mol Med; 2018 Feb; 22(2):913-925. PubMed ID: 29193756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations.
    Novak A; Barad L; Lorber A; Gherghiceanu M; Reiter I; Eisen B; Eldor L; Itskovitz-Eldor J; Eldar M; Arad M; Binah O
    J Cell Mol Med; 2015 Aug; 19(8):2006-18. PubMed ID: 26153920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating
    Shemer Y; Mekies LN; Ben Jehuda R; Baskin P; Shulman R; Eisen B; Regev D; Arbustini E; Gerull B; Gherghiceanu M; Gottlieb E; Arad M; Binah O
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360639
    [No Abstract]   [Full Text] [Related]  

  • 8. Cronos Titin Is Expressed in Human Cardiomyocytes and Necessary for Normal Sarcomere Function.
    Zaunbrecher RJ; Abel AN; Beussman K; Leonard A; von Frieling-Salewsky M; Fields PA; Pabon L; Reinecke H; Yang X; Macadangdang J; Kim DH; Linke WA; Sniadecki NJ; Regnier M; Murry CE
    Circulation; 2019 Nov; 140(20):1647-1660. PubMed ID: 31587567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troponin destabilization impairs sarcomere-cytoskeleton interactions in iPSC-derived cardiomyocytes from dilated cardiomyopathy patients.
    Dai Y; Amenov A; Ignatyeva N; Koschinski A; Xu H; Soong PL; Tiburcy M; Linke WA; Zaccolo M; Hasenfuss G; Zimmermann WH; Ebert A
    Sci Rep; 2020 Jan; 10(1):209. PubMed ID: 31937807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense-mediated exon skipping: a therapeutic strategy for titin-based dilated cardiomyopathy.
    Gramlich M; Pane LS; Zhou Q; Chen Z; Murgia M; Schötterl S; Goedel A; Metzger K; Brade T; Parrotta E; Schaller M; Gerull B; Thierfelder L; Aartsma-Rus A; Labeit S; Atherton JJ; McGaughran J; Harvey RP; Sinnecker D; Mann M; Laugwitz KL; Gawaz MP; Moretti A
    EMBO Mol Med; 2015 May; 7(5):562-76. PubMed ID: 25759365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Titin-truncating mutations associated with dilated cardiomyopathy alter length-dependent activation and its modulation via phosphorylation.
    Vikhorev PG; Vikhoreva NN; Yeung W; Li A; Lal S; Dos Remedios CG; Blair CA; Guglin M; Campbell KS; Yacoub MH; de Tombe P; Marston SB
    Cardiovasc Res; 2022 Jan; 118(1):241-253. PubMed ID: 33135063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells.
    Wyles SP; Li X; Hrstka SC; Reyes S; Oommen S; Beraldi R; Edwards J; Terzic A; Olson TM; Nelson TJ
    Hum Mol Genet; 2016 Jan; 25(2):254-65. PubMed ID: 26604136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutation in the glutamate-rich region of RNA-binding motif protein 20 causes dilated cardiomyopathy through missplicing of titin and impaired Frank-Starling mechanism.
    Beqqali A; Bollen IA; Rasmussen TB; van den Hoogenhof MM; van Deutekom HW; Schafer S; Haas J; Meder B; Sørensen KE; van Oort RJ; Mogensen J; Hubner N; Creemers EE; van der Velden J; Pinto YM
    Cardiovasc Res; 2016 Oct; 112(1):452-63. PubMed ID: 27496873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.
    Sun N; Yazawa M; Liu J; Han L; Sanchez-Freire V; Abilez OJ; Navarrete EG; Hu S; Wang L; Lee A; Pavlovic A; Lin S; Chen R; Hajjar RJ; Snyder MP; Dolmetsch RE; Butte MJ; Ashley EA; Longaker MT; Robbins RC; Wu JC
    Sci Transl Med; 2012 Apr; 4(130):130ra47. PubMed ID: 22517884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholamban as a crucial determinant of the inotropic response of human pluripotent stem cell-derived ventricular cardiomyocytes and engineered 3-dimensional tissue constructs.
    Chen G; Li S; Karakikes I; Ren L; Chow MZ; Chopra A; Keung W; Yan B; Chan CW; Costa KD; Kong CW; Hajjar RJ; Chen CS; Li RA
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):193-202. PubMed ID: 25504561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The assembly and evaluation of antisense oligonucleotides applied in exon skipping for titin-based mutations in dilated cardiomyopathy.
    Hahn JK; Neupane B; Pradhan K; Zhou Q; Testa L; Pelzl L; Maleck C; Gawaz M; Gramlich M
    J Mol Cell Cardiol; 2019 Jun; 131():12-19. PubMed ID: 30998980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Titin-truncating variants in hiPSC cardiomyocytes induce pathogenic proteinopathy and sarcomere defects with preserved core contractile machinery.
    Huang G; Bisaria A; Wakefield DL; Yamawaki TM; Luo X; Zhang JA; Vigneault P; Wang J; Reagan JD; Oliverio O; Zhou H; Li CM; Vila OF; Wang S; Malik FI; Hartman JJ; Hale CM
    Stem Cell Reports; 2023 Jan; 18(1):220-236. PubMed ID: 36525964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-specific induced-pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing.
    Tse HF; Ho JC; Choi SW; Lee YK; Butler AW; Ng KM; Siu CW; Simpson MA; Lai WH; Chan YC; Au KW; Zhang J; Lay KW; Esteban MA; Nicholls JM; Colman A; Sham PC
    Hum Mol Genet; 2013 Apr; 22(7):1395-403. PubMed ID: 23300193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Titin mutations: the fall of Goliath.
    Neiva-Sousa M; Almeida-Coelho J; Falcão-Pires I; Leite-Moreira AF
    Heart Fail Rev; 2015 Sep; 20(5):579-88. PubMed ID: 26024954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressed β-adrenergic inotropic responsiveness and intracellular calcium handling abnormalities in Duchenne Muscular Dystrophy patients' induced pluripotent stem cell-derived cardiomyocytes.
    Mekies LN; Regev D; Eisen B; Fernandez-Gracia J; Baskin P; Ben Jehuda R; Shulman R; Reiter I; Palty R; Arad M; Gottlieb E; Binah O
    J Cell Mol Med; 2021 Apr; 25(8):3922-3934. PubMed ID: 33619882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.